Metropolitan Life Insurance CO Atossa Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$1.6 - $3.27 $24,748 - $50,580	-15,468 Closed	0 $0
Q3 2021 Jun 21, 2023	BUY	$2.89 - $6.4 $44,702 - $98,995	15,468 New	15,468 $50,000
Q3 2021 Mar 30, 2023	SELL	$2.89 - $6.4 $52,652 - $116,601	-18,219 Reduced 54.08%	15,468 $50,000
Q3 2021 Nov 15, 2021	SELL	$2.89 - $6.4 $52,652 - $116,601	-18,219 Reduced 54.08%	15,468 $50,000
Q2 2021 Jun 21, 2023	BUY	$1.52 - $8.62 $51,204 - $290,381	33,687 New	33,687 $212,000
Q2 2021 Mar 30, 2023	BUY	$1.52 - $8.62 $51,204 - $290,381	33,687 New	33,687 $212,000
Q2 2021 Aug 16, 2021	BUY	$1.52 - $8.62 $51,204 - $290,381	33,687 New	33,687 $213,000

29M

39.8K

90.9K

Ticker ATOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,624,000
Market Cap $105M
Description
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.